Utilisation of codeine and propoxyphene: Geographic and demographic variations in prescribing, prescriber and recipient categories

European Journal of Clinical Pharmacology

Volumn 55, Issue 8, 1999, Pages 605-611

  Henricson, K ^a   Carlsten, A ^b   Ranstam, J ^c   Rametsteiner, G ^d   Stenberg, P ^a   Wessling, A ^e   Melander, A ^c  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

^b SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^c Network for Pharmacoepidemiology Foundation   (Sweden)

^d Fasanen Pharmacy   (Sweden)

^e Apoteket AB   (Sweden)

Author keywords

Codeine; Propoxyphene; Utilisation

Indexed keywords

ACETYLSALICYLIC ACID; BENZODIAZEPINE DERIVATIVE; CAFFEINE; CHLORZOXAZONE; COCODAMOL; CODEINE; DEXTROPROPOXYPHENE; DEXTROPROPOXYPHENE PLUS PARACETAMOL; IBUPROFEN; NARCOTIC ANALGESIC AGENT; PHENAZONE;

ADOLESCENT; ADULT; AGED; ARTICLE; COMPUTER SYSTEM; CONTROLLED STUDY; DEMOGRAPHY; DRUG UTILIZATION; FEMALE; GEOGRAPHIC DISTRIBUTION; HUMAN; MALE; PRESCRIPTION; PRIORITY JOURNAL; RECIPIENT; SEX DIFFERENCE; SOCIOECONOMICS; SWEDEN; URBAN RURAL DIFFERENCE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANALGESICS, OPIOID; CODEINE; DRUG UTILIZATION; FEMALE; HUMANS; MALE; MIDDLE AGED; NARCOTICS; PHYSICIAN'S PRACTICE PATTERNS; PRESCRIPTIONS, DRUG; PROPOXYPHENE; SEX FACTORS; SOCIOECONOMIC FACTORS; SWEDEN; URBAN HEALTH;

EID: 0032835192     PISSN: 00316970     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002280050680     Document Type: Article

References (21)

1. Bergman U, Elmes P, Halse M, Halvorsen T, Hood H, Lunde PKM, Sjöqvist F, Wade OL, Westerholm B (1975) The measurements of drug comparison. Drugs for diabetes in Northern Ireland, Norway and Sweden. Eur J Clin Pharmacol 8: 83-89
2. Taboulet F (1991) Comparative consumption of antidiabetic drugs in Britain, France and Germany. Eur J Clin Pharmacol 40: 303-304
3. Vauzelle-Kervroedan F, Bergman U, Forhan A, Stålhammar J, Papoz L (1995) Pattern of treatment and metabolic control in orally treated diabetic patients in France and Sweden. Pharmacoepidemiol Drug Saf 4: 37-44
4. Ekedahl A, Lidbeck J, Lithman T, Noreen D, Melander A (1993) Benzodiazepine prescribing patterns and causes in a high-prescribing Scandinavian community. Eur J Clin Pharmacol 44: 141-146
5. Olsson J, Tollin C, Nilsson S, Melander A (1994) Intercommunity variation of antidiabetic drug utilization and in prevalence of diabetes mellitus. Pharmacoepidemiol Drug Saf 3: 215-221
6. Mölstad S, Hovelius B, Kroon L, Melander A (1990) Prescription of antibiotics to out- patients in hospital clinics, community health centres and private practice. Eur J Clin Pharmacol 39: 9-12
7. Henricson K. Melander E, Mölstad S, Ranstam J, Hanson BS, Rametsteiner G, Stenberg P, Melander A (1998) Intra-urban variation of antibiotics utilization in children: influence of socioeconomic factors. Eur J Clin Pharmacol 54: 653-657
8. Melander A, Henricson K, Stenberg P, Löwenhielm P, Malmvik J, Sternebring B, Kaij L, Bergdahl U (1991) Anxiolytichypnotic drugs: relations between prescribing, abuse and suicide. Eur J Clin Pharmacol 41: 525-529
9. Wessling A, Bergman U, Westerholm B (1991) On the differences in psychotropic drug use between the three major urban areas in Sweden. Eur J Clin Pharmacol 40: 495-500
10. Blennow G, Romelsjö A, Leifman H, Leifman A, Karlsson G (1994) Sedatives and hypnotics in Stockholm: social factors and kinds of use. Am J Public Health 84: 242-246
11. Hedenmalm K, Sundgren M, Granberg K, Spigset O, Dahlqvist R (1997) Urinary excretion of codeine, ethylmorphine, and their metabolites: relation to the CYP2D6 activity. Ther Drug Monit 19: 643-649
12. Tyndale RF, Droll KP, Sellers EM (1997) Genetically deficient CYP2D6 metabolism provides protection against oral opiate dependence. Pharmacogenetics 7: 375-379
13. National Corporation of Pharmacies (1996) Yearly statistical reports by the National Corporation of Pharmacies in Sweden (Apoteket AB) (1981-1996)
14. Lunde PKM, Baksaas I, Halvorsen T, Strömnes B, Öydvin K (1979) In: Bergman U, Grimson A, Westerholm B (eds) Studies in drug utilization. WHO Regional Publication. European Series, Copenhagen 8: 17-28
15. Henricson K, Stenberg P, Rametsteiner G, Ranstam J, Hanson BS, Melander A (1998) Socioeconomic factors, morbidity and drug utilization - an ecological study. Pharmacoepidemiol Drug Saf 7: 261-267
16. Eggen AE, Andrew M (1994) Use of codeine analgesics in a general population. A Norwegian study of moderately strong analgesics. Eur J Clin Pharmacol 46: 491-496
17. Pearson RM (1984) Pharmacokinetics of propoxyphene. Hum Toxicol 3[suppl]: 37S-40S
18. Bergman U, Dahl-Puustinen ML (1989) Use of prescription forgeries in a drug abuse surveillance network. Eur J Clin Pharmacol 36: 621-623
19. Department of Health and Human Services (1985) Drug utilization in the US - 1983. Fifth annual review. Department of Health and Human Services, February
20. Nelson FL (1985-1986) The association of preexisting psychosocial pathology with deaths involving propoxyphene or codeine. Int J Addict 20: 1823-1830
21. Bowen D, et al (1984) Distalgesic; safety and efficacy. Hum Toxicol 3[suppl]: 1S-abstract 2385